Status of the neonatal rat brain after NMDA-induced excitotoxic injury as measured by MRI, MRS and metabolic imaging

NMR in Biomedicine

Volumn 9, Issue 2, 1996, Pages 84-92

  Dijkhuizen, R M ^a,b   Van Lookeren Campagne, M ^c   Niendorf, T ^d   Dreher, W ^d   Van Der Toorn, A ^a   Hoehn Berlage, M ^e   Verbeul, H B ^b   Tulleken, C A F ^b   Leibfritz, D ^d   Hossmann, K A ^e   Nicolay, K ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d UNIVERSITY OF BREMEN   (Germany)

^e MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; N METHYLASPARTIC ACID; PHOSPHORUS;

ANIMAL; ARTICLE; BRAIN DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FLUOROSCOPY; LUMINESCENCE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; WISTAR RAT;

ANIMALS; BRAIN DISEASES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FLUOROSCOPY; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; N-METHYLASPARTATE; PHOSPHORUS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0030130561     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199604)9:2<84::AID-NBM401>3.0.CO;2-B     Document Type: Article

References (50)

1. Rothman, S. M. and Olney, J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19, 105-111 (1986).
2. Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634 (1988).
3. Siesjö, B. K. and Bengtsson, F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9, 127-140 (1989).
4. McDonald, J. W. and Johnston, M. V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15, 41-70 (1990).
5. Meldrum, B. S. and Garthwaite, J. Excitatory amino acid neurotoxicity and neurodegenerative diseases. Trends Neurosci. 11, 379-387 (1990).
6. Beal, M. F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6, 3338-3344 (1992).
7. Simon, R. P., Swan, J. H., Griffiths, T. and Meldrum, B. S. Blockade of NMDA receptor may protect against ischemic damage in the brain. Science 226, 850-852 (1984).
8. Wieloch, T. Hypoglycemia-induced neuronal damage prevented by a N-methyl-D-aspartate antagonist. Science 230, 681-683 (1985).
9. McDonald, J. W., Silverstein, F. S. and Johnston, M. V. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res. 490, 33-40 (1989).
10. 2-weighted MRI and spectroscopy. Magn. Reson. Med. 14, 330-346 (1990).
11. 2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn. Reson. Med. 18, 39-50 (1991).
12. Benveniste, H., Hedlund, L. W. and Johnson, G. A. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke 23, 746-754 (1992).
13. 1H nuclear magnetic resonance imaging. Brain Res. 618, 203-212 (1993).
14. Verheul, H. B., Balázs, R., Berkelbach van der Sprenkel, J. W., Tulleken, C. A. F, Nicolay, K., Tamminga, K. S. and Van Lookeren Campagne, M. Comparison of diffusion- weighted MRI with changes in cell volume in a rat model of brain injury. NMR Biomed. 7, 96-100 (1994).
15. Van Lookeren Campagne, M., Verheul, J. B., Nicolay, K. and Balázs, R. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance and histology. J. Cereb. Blood Flow Metab. 14, 1011-1023 (1994).
16. Busza, A. L., Allen, K. L., King, M. D., Van Bruggen, N., Williams, S. R. and Gadian, D. G. Diffusion-weighted ischemia in gerbils: potential relevance to energy failure. Stroke 23, 1602-1612 (1992).
17. Back, T., Hoehn-Berlage, M., Kohno, K. and Hossmann, K.-A. Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites. Stroke 25, 494-500 (1994).
18. McDonald, J. W. and Johnston, M. V. Quantitative assessment of neuroprotection against NMDA-mediated brain injury. Exp. Neurol. 106, 289-296 (1988).
19. Norris, D. G., Börnert, P., Reese, T. and Leibfritz, D. On the application of ultra-fast RARE experiments. Magn. Reson. Med. 27, 142-164 (1992).
20. Niendorf, T., Van Lookeren Campagne, M., Norris, D. G., Dijkhuizen, R. M., Nicolay, K. and Leibfritz, D. Variation in apparent restricted diffusion as a function of the extracellular space fraction. 14th Annual Meeting of the Society of Magnetic Resonance in Medicine. Abstr., p. 1380 (1994).
21. Le Bihan, D., Breton, E., Lallemand, D., Grenier, P., Cabanis, E. and Laval-Jeantet, M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161, 401-407 (1986).
22. Dreher, W. and Leibfritz, D. Parametric multiecho proton spectroscopic imaging: application to the rat brain in vivo. Magn. Reson. Imag. 13, 753-761 (1995).
23. Mao, J., Mareci, T. H. and Andrew, E. R. Experimental study of optimal selective 180° radiofrequency pulses. J. Magn. Res. 79, 1-10 (1988).
24. 31P NMR signals using the variable projection method and prior knowledge. Magn. Reson. Med. 6, 92-98 (1988).
25. 31P nuclear magnetic resonance spectroscopy. Neurology 35, 781-788 (1985).
26. Csiba, L., Paschen, W. and Hossmann, K.-A. A topographic quantitative method for measuring brain tissue pH under physiological and pathophysiological conditions. Brain Res. 289, 334-337 (1983).
27. Paschen, W., Niebuhr, I. and Hossmann, K.-A. A bioluminescence method for the demonstration of regional glucose distribution in brain slices. J. Neurochem. 36, 513-517 (1981)
28. Paschen, W. Regional quantitative determination of lactate in brain sections. A bioluminescent approach. J. Cereb. Blood Flow Metab. 5, 609-612 (1985).
29. 1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods. Neurochem. Res. 15, 1009-1016 (1990).
30. Tofts, P. and Wray, S. Changes in brain phosphorous metabolites during the post-natal development of the rat. J. Physiol. 359, 417-429 (1985).
31. Ikonomidou, C., Mosinger, J. L., Shahid Salles, K., Labruyere, J. and Olney, J.W. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9, 2809-2818 (1989).
32. Young, R. S. K., Petroff, O. A. C., Aquila, W. J., Yates, J. Effects of glutamate, quisqualate and N-methyl-D-aspartate in neonatal brain. Exp. Neurol. 111, 362-368 (1991).
33. McDonald, J. W., Silverstein, F. S. and Johnston, M. V. MK-801 protects the neonatal brain from hypoxic-tschemic damage. Eur. J. Pharmacol. 140, 359-361 (1987).
34. Kochhar, A., Zivin, J. A., Lyden, P. D. and Mazzarell V. Glutamate antagonist-therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45, 148-153 (1988).
35. Nozaki, K. and Beal, M. F. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J. Cereb. Blood Flow Metab. 12, 400-407 (1992).
36. Novelli, A., Reilly, J. A., Lysko, P. G. and Henneberry, R. C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212 (1988).
37. Beal, M. F., Hyman, B. T. and Koroshetz, W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131 (1993).
38. Palmer, C., Brucklacher, R. M., Christensen, M. A. and Vannucci, R. C. Carbohydrate and energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. J. Cereb. Blood Flow Metab. 10, 227-235 (1990).
39. Yager, J. Y., Brucklacher, R. M. and Vannucci, R. C. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am. J. Physiol. 262, H672-H677 (1992).
40. Vannucci, R. C., Christensen, M. A. and Yager, J. Y. Nature, time-course and extent of cerebral edema in perinatal hypoxic-ischemic brain damage. Pediatr. Neurol. 9, 29-34 (1993).
41. Siesjö, B. K. Cell damage in the brain: a speculative synthesis. J. Cereb. Blood Flow Metab. 1, 155-185 (1981).
42. Siesjö, B. K. Pathophysiology and treatment of focal cerebral ischemia. Part I: pathophysiology. J. Neurosurg. 77, 169-184 (1992).
43. Raichle, M. E. The pathophysiology of brain ischemia. Ann. Neurol. 13, 2-10 (1983).
44. Dreher, W., Kühn, B., Gyngell, M. L., Busch, E., Niendorf, T., Hossmann, K.-A. and Leibfritz, D. Proton spectroscopic imaging and diffusion MRI studies of focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 15, S356 (1995).
45. Zhong, J., Petroff, O. A. C., Prichard, J. W. and Gore, J. C. Changes in water diffusion and relaxation properties of rat cerebrum during status epilepticus. Magn. Reson. Med. 30, 241-246 (1993).
46. Vannucci, R. C., Hellmann, J., Hernandez, M. J. and Vannucci, S. J. Lactic acid as an energy source in perinatal brain. In Cerebral Metabolism and Neural Function, ed. by J. V. Passonneau, R. A. Hawkins, W. D. Lust and F. A. Welch, pp. 264-270. Williams and Wilkins, Baltimore, MD (1980).
47. Vannucci, R. C. and Yager, J. Y. Glucose, lactic acid and perinatal hypoxic-ischemic brain damage. Pediatr, Neurol. 8, 3-12 (1992).
48. Duffy, T. E., Kohle, S. J. and Vannucci, R. C. Carbohydrate and energy metabolism in perinatal rat brain: relation to survival in anoxia. J. Neurochem. 24, 271-276 (1975).
49. Hattori, H. and Wasterlain, C. G. Excitatory amino acids in the developing brain: ontogeny, plasticity and excitotoxicity. Pediatr. Neurol. 6, 219-228 (1990).
50. Hossmann, K.-A. Glutamate-mediated injury in focal cerebral ischemia; the excitotoxin hypothesis revised. Brain Pathol. 4, 23-36 (1994).